| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC | SVP, Strategy & Corporate Dev | Common Stock | 561 | $135,324 | $241.12 | 20 Feb 2026 | Direct |
| WEST PHARMACEUTICAL SERVICES INC | SVP, Strategy & Corporate Dev | Stock Option (Right to Buy) | 1,040 | 01 Mar 2026 | Direct | ||
| WEST PHARMACEUTICAL SERVICES INC | SVP, Strategy & Corporate Dev | Rst. Stock Unit | 437 | 01 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| WST | WEST PHARMACEUTICAL SERVICES INC | 01 Mar 2026 | 2 | $0 | 4 | SVP, Strategy & Corporate Dev | 03 Mar 2026, 11:24 |
| WST | WEST PHARMACEUTICAL SERVICES INC | 20 Feb 2026 | 3 | -$31,236 | 4 | SVP, Strategy & Corporate Dev | 23 Feb 2026, 17:44 |
| WST | WEST PHARMACEUTICAL SERVICES INC | 18 Feb 2026 | 3 | -$6,904 | 4 | SVP, Strategy & Corporate Dev | 19 Feb 2026, 19:05 |
| WST | WEST PHARMACEUTICAL SERVICES INC | 23 Jul 2025 | 0 | $0 | 3 | SVP, Strategy & Corporate Dev | 01 Aug 2025, 16:14 |